The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2018 | The key unanswered question in lung cancer?
At the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, we asked a range of experts what they thought the key unanswered question in lung cancer is currently. They were all in agreement that there are a range of issues to address, but each speaker had their own take on the question. Ranging from disease biology to early diagnosis and policy, see what the experts thought.
